Minerva Neurosciences Statistics
NASDAQ: NERVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.23-0.04 (-1.22%)
Market open · Delayed 15 min · as of Oct 8, 11:03 AM ET
Minerva Neurosciences by the numbers
Minerva Neurosciences has a market capitalization of $154.2 million based on 47.75M shares outstanding. With trailing EPS of $-36.12, Minerva Neurosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.4% below its 50-day average and 36.0% below its 200-day average.
Average daily trading volume is 184.44K shares, or about $595,751 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NERV valuation vs. peer median
| Metric | NERV | Peer median | Difference |
|---|---|---|---|
| Market cap | $154.22M | $156.79M | -2% |
| Avg. volume | 184.44K | 330.88K | -44% |
Peer median across 8 companies: NBP, MENS, VRXA, CUE, NKTX, ALXO, KRRO, PEPG.
Valuation
- Market cap
- $154.22M
- EPS (TTM)
- $-36.12
- Shares outstanding
- 47.75M
Price and trading
- Previous close
- 3.27
- Open
- 3.25
- Day range
- 3.14 – 3.28
- 52-week range
- 2.24 – 12.46
- 52-week change
- +50.00%
- Beta
- —
- Volume
- 14.81K
- Average volume
- 184.44K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 154.22M
- Forward Pe
- -7.69
- Eps
- -36.12
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.46
- Week52 Low
- 2.24
- Avg Volume
- 184.44K
- Shares Outstanding
- 47.75M
- Ma50
- 4.11
- Ma200
- 5.05
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -74.08%
- Pct From52w Low
- 44.33%